Profile data is unavailable for this security.
About the company
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples. Pittsburgh segment also develops tumor-specific in vitro models for oncology drug discovery and research. Birmingham segment focuses on contract services and research for biopharmaceutical company clients and academic collaborators, focused on solubility improvements, stability studies, and protein production. Specifically, Birmingham provides optimized formulations for vaccines, antibodies, and other protein therapeutics. Eagan segment produces the STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal.
- Revenue in USD (TTM)1.78m
- Net income in USD-13.98m
- Incorporated2013
- Employees34.00
- LocationPredictive Oncology Inc91 43RD STREET, SUITE 110PITTSBURGH 15201United StatesUSA
- Phone+1 (412) 432-1500
- Fax+1 (651) 379-5024
- Websitehttps://predictive-oncology.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Venus Concept Inc | 76.35m | -37.25m | 4.19m | 304.00 | -- | -- | -- | 0.0549 | -6.86 | -6.86 | 14.05 | -2.54 | 0.6972 | 1.03 | 2.30 | 251,164.50 | -33.83 | -32.71 | -50.39 | -44.01 | 68.32 | 68.16 | -48.52 | -48.50 | 1.39 | -3.93 | 1.22 | -- | -23.26 | 28.31 | 14.76 | -- | -35.08 | -- |
| Sharps Technology Inc | 0.00 | -9.84m | 4.20m | 3.00 | -- | 0.5157 | -- | -- | -0.7645 | -0.7645 | 0.00 | 0.5195 | 0.00 | -- | -- | -- | -83.30 | -- | -109.78 | -- | -- | -- | -- | -- | 0.8474 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
| Encision Inc | 6.87m | -448.00k | 4.32m | 31.00 | -- | 1.97 | -- | 0.6293 | -0.0381 | -0.0381 | 0.5835 | 0.1863 | 1.64 | 1.96 | 7.84 | 221,520.00 | -10.69 | -1.07 | -14.05 | -1.46 | 50.54 | 52.27 | -6.52 | -0.613 | 1.08 | -6.22 | 0.1123 | -- | -4.17 | -3.44 | -393.90 | -- | 12.89 | -- |
| Acutus Medical Inc | 7.16m | -11.92m | 4.46m | 233.00 | -- | -- | -- | 0.6222 | -0.4097 | -0.417 | 0.2467 | -0.0308 | 0.0765 | 1.17 | 0.4417 | 30,746.78 | -12.72 | -46.76 | -16.05 | -56.88 | -43.79 | -89.12 | -166.40 | -773.49 | 2.22 | -6.78 | 1.03 | -- | 136.36 | 27.03 | -141.35 | -- | -35.99 | -- |
| BIOLASE Inc | 49.16m | -37.62m | 4.93m | 157.00 | -- | -- | -- | 0.1003 | -37.97 | -37.97 | 38.54 | 0.5726 | 1.34 | 2.38 | 8.68 | 313,146.50 | -56.30 | -49.28 | -115.21 | -85.80 | 34.02 | 35.27 | -41.97 | -50.72 | 0.683 | -6.61 | 0.8778 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
| Bioelectronics Corp | 1.61m | -289.82k | 4.94m | 9.00 | -- | -- | -- | 3.07 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
| Pressure Biosciences Inc | 2.27m | -29.56m | 5.18m | 15.00 | -- | -- | -- | 2.28 | -1.70 | -1.70 | 0.1299 | -1.22 | 1.02 | 2.28 | 9.17 | 151,505.30 | -1,074.63 | -643.54 | -- | -- | 6.89 | 34.75 | -1,050.30 | -798.21 | 0.0185 | -0.4182 | -- | -- | -13.64 | -5.05 | 21.52 | -- | -34.47 | -- |
| ADM Tronics Unlimited Inc | 2.85m | -716.86k | 5.41m | 7.00 | -- | 4.90 | -- | 1.90 | -0.0106 | -0.0106 | 0.0421 | 0.0163 | 0.9772 | 3.85 | 4.25 | -- | -24.62 | -11.45 | -38.81 | -15.77 | 38.45 | 43.73 | -25.19 | -15.28 | 1.24 | -- | 0.2902 | -- | 14.66 | -0.4159 | 93.04 | -- | -- | -- |
| Nu-Med Plus Inc | 0.00 | -125.53k | 5.41m | 2.00 | -- | -- | -- | -- | -0.0015 | -0.0015 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -269.93 | -447.69 | -- | -- | -- | -- | -- | -- | -- | -24.11 | -- | -- | -- | -- | 3.56 | -- | -- | -- |
| Arch Therapeutics Inc | 115.33k | -7.86m | 5.60m | 8.00 | -- | -- | -- | 48.52 | -4.07 | -4.07 | 0.0509 | -2.02 | 0.0652 | 0.0613 | -- | 14,416.25 | -444.57 | -188.28 | -- | -804.63 | 27.04 | -- | -6,819.08 | -26,945.92 | 0.042 | -2.02 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
| Predictive Oncology Inc | 1.78m | -13.98m | 5.73m | 34.00 | -- | 0.6926 | -- | 3.22 | -3.48 | -3.48 | 0.4434 | 2.04 | 0.0887 | 1.37 | 5.35 | 52,355.88 | -69.66 | -91.80 | -86.54 | -126.29 | 64.34 | 64.64 | -785.57 | -1,419.99 | 2.43 | -- | 0.0179 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
| Heart Test Laboratories Inc | 18.60k | -6.39m | 6.06m | 12.00 | -- | 0.6808 | -- | 325.69 | -0.4912 | -0.4912 | 0.0009 | 0.1357 | 0.0026 | 0.009 | 2.53 | 1,550.00 | -89.51 | -- | -120.71 | -- | 67.31 | -- | -34,362.42 | -- | 4.70 | -16.41 | 0.0547 | -- | -64.16 | -- | -31.61 | -- | -- | -- |
| Guided Therapeutics Inc | 98.00k | -3.76m | 6.06m | 4.00 | -- | -- | -- | 61.86 | -0.074 | -0.074 | 0.0019 | -0.0703 | 0.0389 | 0.1051 | 15.08 | 24,500.00 | -138.59 | -136.13 | -- | -- | 36.73 | 29.39 | -3,560.20 | -3,666.67 | 0.1582 | -12.94 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| Avinger Inc | 7.65m | -18.32m | 6.37m | 68.00 | -- | -- | -- | 0.832 | -26.38 | -26.38 | 9.74 | -4.85 | 0.4031 | 1.10 | 7.39 | 112,529.40 | -96.51 | -70.93 | -5,095.97 | -131.57 | 26.18 | 30.87 | -239.41 | -208.91 | 0.3557 | -9.68 | 1.77 | -- | -7.51 | -0.6736 | 32.76 | -- | -24.21 | -- |
| Sonendo Inc | 43.87m | -60.92m | 6.59m | 216.00 | -- | 0.2092 | -- | 0.1503 | -0.6485 | -0.6485 | 0.4667 | 0.4472 | 0.4072 | 2.38 | 8.06 | 203,078.70 | -56.55 | -- | -74.56 | -- | 28.05 | -- | -138.88 | -- | 1.53 | -17.04 | 0.568 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
| Fuse Medical Inc | 18.40m | 3.63m | 7.02m | 31.00 | 2.64 | -- | 1.90 | 0.3815 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
Data as of May 01 2024. Currency figures normalised to Predictive Oncology Inc's reporting currency: US Dollar USD
9.01%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 31 Dec 2023 | 139.18k | 3.43% |
| Raymond James & Associates, Inc. (Invt Mgmt)as of 31 Mar 2024 | 120.81k | 2.97% |
| Geode Capital Management LLCas of 31 Dec 2023 | 37.47k | 0.92% |
| RB Capital Management LLCas of 31 Dec 2023 | 20.84k | 0.51% |
| SSgA Funds Management, Inc.as of 31 Dec 2023 | 16.84k | 0.41% |
| Renaissance Technologies LLCas of 31 Dec 2023 | 14.18k | 0.35% |
| Carnegie Mellon University (Investment Management)as of 31 Dec 2023 | 10.36k | 0.26% |
| UBS Securities LLCas of 31 Dec 2023 | 2.56k | 0.06% |
| Tower Research Capital LLCas of 31 Dec 2023 | 2.39k | 0.06% |
| Vanguard Global Advisers LLCas of 31 Dec 2023 | 1.43k | 0.04% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
